← Evidence map

ReviewPain management2025

Buvidal/Brixadi - a long-acting injectable buprenorphine formulation for the treatment of opioid dependence.

Nicholas Lintzeris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40891214